Logo

American Heart Association

  38
  0


Final ID:

Discussant: CAVIAR

  • Kobashigawa, Jon  ( CEDARS-SINAI HEART INSTITUTE , Los Angeles , California , United States )
  • Lavine, Kory  ( WASHINGTON UNIVERSITY SCHOOL OF MED , Saint Louis , Missouri , United States )
  • Kopecky, Benjamin  ( University of Colorado , Aurora , Colorado , United States )
  • Author Disclosures:
    Jon Kobashigawa: No Answer | Kory Lavine: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen:Active (exists now) ; Advisor:SUN/SPARC:Active (exists now) ; Advisor:Souffle:Active (exists now) ; Advisor:RiverVest:Active (exists now) ; Advisor:Kiniksa:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Implicit:Active (exists now) ; Research Funding (PI or named investigator):Bitterroot:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) | Benjamin Kopecky: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Recipes for Success in Heart Failure

Monday, 11/10/2025 , 09:45AM - 11:00AM

Late-Breaking Science

More abstracts on this topic:
A Polypill Strategy for Heart Failure with Reduced Ejection Fraction: The POLY-HF Trial

Pandey Ambarish, Wang Thomas, Keshvani Neil, Rizvi Syed Kazim, Jain Anand, Coellar Juan David, Drazner Mark, Gupta Deepak, Chandra Alvin, Zaha Vlad

Cardiac Allograft Vasculopathy Inhibition with AliRocumab:
The CAVIAR Trial

Fearon William, Terada Kossei, Skoda Anette, Luikart Helen, Knowles Josh, Honda Yasuhiro, Woo Christopher, Teuteberg Jeffrey, Khush Kiran

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available